S. 1734/H.R. 2182, Generating Antibiotic Incentives Now Act (GAIN Act) - incentives for development of products to treat antibiotic-resistant infections, issues concerning technical clarifications.
S. 3187, Food and Drug Adminitration Safety and Innovations Act - incentives for development of products to treat antibiotic-resistant infections H.R. 5651, Food and Drug Administration Reform Act of 2012 - incentives for development of products to treat antibiotic-resistant infections
S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013.
H.J. Res. 117, Continuing Approprations Resolution
Medical Research
Antibiotic resistance issues
Reauthorization of the Prescrition Drug User Fee Act
Reauthorization of the Medical Device User Fee Act
H.R. 1483, Drug and Safety Enhancement Act of 2011
Implementation of Patient Protaction and Affordable Care Act of 2010 (Pub. L. 111-148)
Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Medicare home infusion and reimbusement issues
340B Drug Pricing program issues, including program expansion
H.R. 2195/S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions) Pub. L. 111-148, Patient Protection and Affortable Care Act (implementation).
Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H..Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions)
H..R.. 5973/S 2375, Agriculture, Rural Development, Food and Drug  Administration and Related Agencies Appropriations Act, 2013
H..J. Res 117, Continuing Appropriations Resolutions 2013
Issues concerning the impact of the sequestration on prescription drug user fees. Antibiotic resistance issues.
Pay-for-delay proposals and generic issues.
H.R. 2182/ S. 1734, Generating Antibiotic Incentives Now Act of 2011-incentives for development of products to treat antibiotic-resistant infections Prescription Drug User Fee Act reauthorization.
H.R. 5651, Food and Drug Adminitration Reform Act of 2012 - incentives for development of products to treat antibiotic-resistant infections
S. 2516,  Food and Drug Administration Safety and Innovation Act.
S. 3187,  Food and Drug Administration Safety and Innovation Act.- incentives for development of products to treat antibiotic-resistant infections
S. 2292, Patients' FDA Act
S. 2289, Better Pharmaceuticals and Devices for Childrens Act of 2012
H.R. 6433, FDA User Fee Corrections Act of 2012
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CUBIST PHARMACEUTICALS, INC.
65 Hayden Avenue, Lexington, MA, 02421, US
MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES MARK THOMAS BATTAGLINI GINETTE ELISE RHODES